The global microbiome sequencing services market size reached US$ 2.21 billion in 2023. Looking forward, the publisher expects the market to reach US$ 9.97 billion by 2032, exhibiting a growth rate (CAGR) of 18.18% during 2023-2032. The increasing incidences of infectious diseases among the masses, rising inclination towards microbiome-based therapeutics, including FMT, and the growing adoption of microbiome sequencing in veterinary medicine are some of the major factors propelling the market.
Microbiome sequencing services involve the analysis of microbial communities that inhabit various environments, including the human body. They are specialized procedures designed to identify and analyze the diverse microorganisms living in a particular ecosystem, such as the human gut, soil, or water. They use advanced deoxyribonucleic acid (DNA) sequencing technologies to decode the genetic material of microorganisms, which allows researchers and healthcare professionals to understand the composition, diversity, and function of these microbial communities.
Increasing incidences of infectious diseases among the masses are catalyzing the demand for microbiome sequencing services for studying host-pathogen relationships, which lead to rising demand for its services around the world. Moreover, the rising inclination towards microbiome-based therapeutics, including fecal microbiota transplantation (FMT), that necessitates accurate microbiome profiling to ensure treatment efficacy and safety is favoring the growth of the market. Apart from this, the growing adoption of microbiome sequencing in veterinary medicine for understanding animal health, disease prevention, and improving livestock production is influencing the market positively.
In addition, the expansion of the pharmaceutical industry is driving the use of microbiome data to develop novel drugs, particularly those targeting gastrointestinal diseases, which is contributing to the market growth. Furthermore, the increasing adoption of precision agriculture practices, which rely on data-driven decision-making, is bolstering the market growth.
Whether it is optimizing probiotic regimens, guiding dietary recommendations, or predicting drug efficacy, microbiome data is indispensable. Patients and healthcare providers increasingly seek these insights to achieve better treatment outcomes, minimize adverse effects, and enhance overall wellness. Consequently, the demand for microbiome sequencing services is rising as personalized medicine is becoming a central tenet of modern healthcare.
As consumers gain a better understanding of the connections between their microbiome and various health aspects, they are turning to microbiome sequencing services for in-depth analysis and personalized recommendations. This surge in interest from the public is propelling the demand for microbiome sequencing services, as individuals seek to make informed lifestyle choices and dietary adjustments to promote a healthier microbiome.
The increasing knowledge about the advantages of early diagnosis and disease detection represents one of the primary factors driving the demand for microbiome sequencing services in the North American region. Moreover, the surging prevalence of colorectal cancer (CRC) is favoring the growth of the market in the region. Besides this, the growing geriatric population, that are more prone to develop severe medical conditions, is influencing the market positively in the region.
Asia Pacific is estimated to witness stable growth, owing to increasing investment in developing novel drugs, extensive research and development (R&D) activities, integration of advanced technologies, etc.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
2. What is the expected growth rate of the global microbiome sequencing services market during 2024-2032?
3. What are the key factors driving the global microbiome sequencing services market?
4. What has been the impact of COVID-19 on the global microbiome sequencing services market?
5. What is the breakup of the global microbiome sequencing services market based on the technology?
6. What is the breakup of the global microbiome sequencing services market based on the research type?
7. What is the breakup of the global microbiome sequencing services market based on the laboratory type?
8. What is the breakup of the global microbiome sequencing services market based on the application?
9. What is the breakup of the global microbiome sequencing services market based on the end user?
10. What are the key regions in the global microbiome sequencing services market?
11. Who are the key players/companies in the global microbiome sequencing services market?
Microbiome sequencing services involve the analysis of microbial communities that inhabit various environments, including the human body. They are specialized procedures designed to identify and analyze the diverse microorganisms living in a particular ecosystem, such as the human gut, soil, or water. They use advanced deoxyribonucleic acid (DNA) sequencing technologies to decode the genetic material of microorganisms, which allows researchers and healthcare professionals to understand the composition, diversity, and function of these microbial communities.
Increasing incidences of infectious diseases among the masses are catalyzing the demand for microbiome sequencing services for studying host-pathogen relationships, which lead to rising demand for its services around the world. Moreover, the rising inclination towards microbiome-based therapeutics, including fecal microbiota transplantation (FMT), that necessitates accurate microbiome profiling to ensure treatment efficacy and safety is favoring the growth of the market. Apart from this, the growing adoption of microbiome sequencing in veterinary medicine for understanding animal health, disease prevention, and improving livestock production is influencing the market positively.
In addition, the expansion of the pharmaceutical industry is driving the use of microbiome data to develop novel drugs, particularly those targeting gastrointestinal diseases, which is contributing to the market growth. Furthermore, the increasing adoption of precision agriculture practices, which rely on data-driven decision-making, is bolstering the market growth.
Microbiome Sequencing Services Market Trends/Drivers:
Increase in personalized medicine and therapies
With the rising use of personalized medicine, there is a rise in the demand for microbiome sequencing services to offer tailoring treatments and interventions to individual patients. One of the driving forces behind the demand for microbiome sequencing services is the recognition that each microbiome of a person is unique and can significantly impact their response to treatments.Whether it is optimizing probiotic regimens, guiding dietary recommendations, or predicting drug efficacy, microbiome data is indispensable. Patients and healthcare providers increasingly seek these insights to achieve better treatment outcomes, minimize adverse effects, and enhance overall wellness. Consequently, the demand for microbiome sequencing services is rising as personalized medicine is becoming a central tenet of modern healthcare.
Rise in consumer awareness and wellness
Consumer awareness about the role of microbiomes in health and wellness has been steadily increasing. People are becoming more proactive about their health, seeking ways to optimize their microbiomes for improved well-being. This trend is driven by the availability of direct-to-consumer microbiome testing kits that provide individuals with insights into their gut microbiota.As consumers gain a better understanding of the connections between their microbiome and various health aspects, they are turning to microbiome sequencing services for in-depth analysis and personalized recommendations. This surge in interest from the public is propelling the demand for microbiome sequencing services, as individuals seek to make informed lifestyle choices and dietary adjustments to promote a healthier microbiome.
Growing regulatory requirements and quality assurance
Regulatory bodies in healthcare, agriculture, and food safety are increasingly recognizing the importance of microbiome data in ensuring safety and quality standards. For instance, in the food industry, microbiome sequencing is used to monitor and improve food safety by identifying potential pathogens or spoilage organisms. Similarly, regulatory agencies in agriculture may require microbiome assessments to ensure sustainable farming practices. Compliance with these regulations necessitates the utilization of microbiome sequencing services to maintain high-quality standards, leading to a consistent demand from businesses and organizations striving to meet regulatory requirements and ensure the safety of their products.Microbiome Sequencing Services Industry Segmentation:
The publisher provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology, research type, laboratory type, application, and end user.Breakup by Technology:
- Sequencing by Synthesis (SBS)
- Sequencing by Ligation (SBL)
- Pyrosequencing
- Sanger Sequencing
- Others
Sequencing by synthesis (SBS) dominates the market
Breakup by Research Type:
- Outsourced Research
- Internal Research
Outsourced research holds the largest share in the market
Breakup by Laboratory Type:
- Dry Labs
- Wet Labs
Wet labs hold the largest share in the market
Breakup by Application:
- Shotgun Sequencing
- Targeted Gene Sequencing
- RNA Sequencing
- Whole Genome Sequencing
- Others
Shotgun sequencing holds the largest share in the market
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
- Others
Pharmaceutical and biotechnology companies dominate the market
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest microbiome sequencing services market share
The increasing knowledge about the advantages of early diagnosis and disease detection represents one of the primary factors driving the demand for microbiome sequencing services in the North American region. Moreover, the surging prevalence of colorectal cancer (CRC) is favoring the growth of the market in the region. Besides this, the growing geriatric population, that are more prone to develop severe medical conditions, is influencing the market positively in the region.
Asia Pacific is estimated to witness stable growth, owing to increasing investment in developing novel drugs, extensive research and development (R&D) activities, integration of advanced technologies, etc.
Competitive Landscape:
The leading companies are adopting the use of high throughput sequencing in microbiome sequencing services to enable the simultaneous analysis of numerous microbial samples, which facilitates large-scale studies and delivers high-resolution data on microbial community composition. They are also using metagenomics that allows researchers to sequence the DNA of an entire microbial community in a sample without isolating individual species and enables a holistic view of the microbiome. Moreover, key players are integrating artificial intelligence (AI) and machine learning (ML) into microbiome data analysis that help identify patterns, predict microbial interactions, and discover biomarkers associated with health or disease, which enhances the interpretability of complex microbiome datasets.The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- BaseClear B.V.
- Clinical-Microbiomics A/S
- Diversigen Inc (OraSure Technologies Inc.)
- Mérieux NutriSciences
- Metabiomics Corporation (BioSpherex LLC)
- Microbiome Insights Inc.
- Microbiome Therapeutics LLC
- Molecular Research LP
- Molzym GmbH & Co. KG
- Resphera Biosciences LLC
- Shanghai Realbio Technology (RBT) Co. Ltd.
- Zymo Research Corporation
Recent Developments:
- In 2022, Diversigen Inc (OraSure Technologies Inc.) launched metatranscriptomic sequencing and analysis services for gut microbiome samples.
Key Questions Answered in This Report
1. What was the size of the global microbiome sequencing services market in 2023?2. What is the expected growth rate of the global microbiome sequencing services market during 2024-2032?
3. What are the key factors driving the global microbiome sequencing services market?
4. What has been the impact of COVID-19 on the global microbiome sequencing services market?
5. What is the breakup of the global microbiome sequencing services market based on the technology?
6. What is the breakup of the global microbiome sequencing services market based on the research type?
7. What is the breakup of the global microbiome sequencing services market based on the laboratory type?
8. What is the breakup of the global microbiome sequencing services market based on the application?
9. What is the breakup of the global microbiome sequencing services market based on the end user?
10. What are the key regions in the global microbiome sequencing services market?
11. Who are the key players/companies in the global microbiome sequencing services market?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Microbiome Sequencing Services Market
6 Market Breakup by Technology
7 Market Breakup by Research Type
8 Market Breakup by Laboratory Type
9 Market Breakup by Application
10 Market Breakup by End User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- BaseClear B.V.
- Clinical-Microbiomics A/S
- Diversigen Inc (OraSure Technologies Inc.)
- Mérieux NutriSciences
- Metabiomics Corporation (BioSpherex LLC)
- Microbiome Insights Inc.
- Microbiome Therapeutics LLC
- Molecular Research LP
- Molzym GmbH & Co. KG
- Resphera Biosciences LLC
- Shanghai Realbio Technology (RBT) Co. Ltd.
- Zymo Research Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 2219.3 Million |
| Forecasted Market Value ( USD | $ 9979.3 Million |
| Compound Annual Growth Rate | 18.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
